EVERCORE INC - A (NYSE:EVR) reported second-quarter results that topped analyst expectations on both revenue and earnings, driven by record advisory and underwriting fees. However, the stock edged slightly lower in pre-market trading, perhaps reflecting profit-taking after a strong recent run or cautious positioning ahead of broader market uncertainty.
Results at a Glance
For the quarter ended June 30, 2026, Evercore posted adjusted net revenues of $999.5 million, well above the consensus estimate of $934.9 million. Adjusted diluted earnings per share came in at $2.91, surpassing the $2.79 that analysts had projected.
- Adjusted net revenues: $999.5 million vs. estimate $934.9 million (beat by ~6.9%)
- Adjusted EPS: $2.91 vs. estimate $2.79 (beat by ~4.2%)
- GAAP net revenues: $990.2 million, up 19% year over year
- GAAP operating margin: 14.8% (20.0% on an adjusted basis)
The investment banking & equities segment was the primary driver. Advisory fees rose 11% to $775.6 million, while underwriting fees more than tripled to $97.1 million, reflecting a surge in deal activity including roles on the largest biotech IPO ever and several multi-billion-dollar M&A assignments.
Market Reaction and Context
Despite the headline beat, shares were indicated roughly 0.15% lower in pre-market trading. The modest decline may owe to the stock’s recent strength—Evercore gained about 1.7% over the past month and nearly 5.9% over the last two weeks—leaving little room for an immediate post-earnings pop. Additionally, the company did not provide explicit forward guidance in its press release, which can leave investors focusing on the run-up rather than the beat.
Segment Strength and Capital Returns
The quarter featured broad-based momentum. Evercore’s North America strategic advisory, private funds group, and equities businesses each delivered record second-quarter revenues, while underwriting and wealth management posted their best quarters ever. The firm also announced a quarterly dividend of $0.89 per share and returned $822.9 million to shareholders through dividends and buybacks in the first half of 2026.
Non-compensation costs rose 34% year over year, driven by higher travel, professional fees, and technology spending tied to elevated business activity. The adjusted compensation ratio improved to 63.5% from 65.4% a year ago, reflecting the strong revenue base.
Looking Ahead
Analyst estimates for the current quarter call for adjusted revenue of approximately $1.057 billion and EPS of $3.73, while the full-year consensus sits at $4.80 billion in revenue and $19.91 in EPS. Evercore’s robust pipeline and recent hires—including seven new senior managing directors committed to join—support the optimistic outlook, even as the firm remains exposed to the cyclical nature of M&A and capital markets activity.
For a deeper look at Evercore’s past earnings performance and key financial trends, investors can review the historical earnings data. To track the latest analyst projections and future estimates, visit the forward estimates page.
Disclaimer: This article is for informational and educational purposes only and does not constitute financial advice or a recommendation to buy or sell any security. Always conduct your own research and consider your risk tolerance before making investment decisions.
Read full article here »
View the Zacks #1 Rank List
Evercore (NYSE:EVR) Beats Q2 Estimates on Record Advisory and Underwriting Fees, Shares Edge Lower
EVERCORE INC - A (NYSE:EVR) reported second-quarter results that topped analyst expectations on both revenue and earnings, driven by record advisory and underwriting fees. However, the stock edged slightly lower in pre-market trading, perhaps reflecting profit-taking after a strong recent run or cautious positioning ahead of broader market uncertainty.
Results at a Glance
For the quarter ended June 30, 2026, Evercore posted adjusted net revenues of $999.5 million, well above the consensus estimate of $934.9 million. Adjusted diluted earnings per share came in at $2.91, surpassing the $2.79 that analysts had projected.
The investment banking & equities segment was the primary driver. Advisory fees rose 11% to $775.6 million, while underwriting fees more than tripled to $97.1 million, reflecting a surge in deal activity including roles on the largest biotech IPO ever and several multi-billion-dollar M&A assignments.
Market Reaction and Context
Despite the headline beat, shares were indicated roughly 0.15% lower in pre-market trading. The modest decline may owe to the stock’s recent strength—Evercore gained about 1.7% over the past month and nearly 5.9% over the last two weeks—leaving little room for an immediate post-earnings pop. Additionally, the company did not provide explicit forward guidance in its press release, which can leave investors focusing on the run-up rather than the beat.
Segment Strength and Capital Returns
The quarter featured broad-based momentum. Evercore’s North America strategic advisory, private funds group, and equities businesses each delivered record second-quarter revenues, while underwriting and wealth management posted their best quarters ever. The firm also announced a quarterly dividend of $0.89 per share and returned $822.9 million to shareholders through dividends and buybacks in the first half of 2026.
Non-compensation costs rose 34% year over year, driven by higher travel, professional fees, and technology spending tied to elevated business activity. The adjusted compensation ratio improved to 63.5% from 65.4% a year ago, reflecting the strong revenue base.
Looking Ahead
Analyst estimates for the current quarter call for adjusted revenue of approximately $1.057 billion and EPS of $3.73, while the full-year consensus sits at $4.80 billion in revenue and $19.91 in EPS. Evercore’s robust pipeline and recent hires—including seven new senior managing directors committed to join—support the optimistic outlook, even as the firm remains exposed to the cyclical nature of M&A and capital markets activity.
For a deeper look at Evercore’s past earnings performance and key financial trends, investors can review the historical earnings data. To track the latest analyst projections and future estimates, visit the forward estimates page.
Disclaimer: This article is for informational and educational purposes only and does not constitute financial advice or a recommendation to buy or sell any security. Always conduct your own research and consider your risk tolerance before making investment decisions.
Read full article here »